Supplementary Table 4 from Using Pharmacokinetic and Pharmacodynamic Data in Early Decision Making Regarding Drug Development: A Phase I Clinical Trial Evaluating Tyrosine Kinase Inhibitor, AEE788

Authors :: Chris H. Takimoto
Erika Martinelli
Allan van Oosterom
Eric Walk
Kathryn Parker
Margaret Dugan
Jerry Huang
Christie Low
William Mietlowski
Clifford DiLea
Josep Tabernero
Frederico Rojo
Herlinde Dumez
Patrick Schöffski
Alain C. Mita
José Baselga
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 59K, Pharmacodynamic Parameters

Full Text Access

Tools